Oxygen Times launches SomniScan, India’s first branded at‑home sleep diagnostic solution

New Delhi-based startup Oxygen Times has announced the launch of SomniScan, a branded at-home sleep diagnostic solution designed to bring advanced sleep testing directly into Indian homes.

With growing awareness of sleep health and a large burden of undiagnosed sleep disorders, SomniScan aims to establish a new benchmark in diagnostic accuracy, clinical reliability, and patient convenience across India.

SomniScan represents a significant evolution in sleep diagnostics by offering hospital‑grade sleep studies that are manually scored and clinically interpreted by certified sleep professionals.

Unlike generic or local sleep tests that may rely solely on basic automated scoring, SomniScan adheres to the latest AASM 3.0 standards and incorporates detailed manual scoring to ensure high sensitivity in detecting even subtle abnormalities in breathing patterns, oxygen desaturation, airflow limitations, snoring severity, and body positions changes during sleep.

The at-home sleep study under the SomniScan brand is offered at an accessible starting price, positioning it among the most affordable yet comprehensive sleep diagnostics available in India. The Level 3 sleep study, suitable for identifying conditions such as obstructive sleep apnea, is available at a price of Rs 1,899, while advanced polysomnography options for more complex or severe sleep disorders are offered at approximately Rs 6,000. Reports are delivered within 24 hours, enabling timely clinical decision-making and treatment planning.